-
FROM TRADITIONAL TO ADVANCED: Drug delivery market on the growth curve in Asia
biospectrumasia
July 27, 2017
Advanced drug delivery technologies hold a major part of drug delivery market and will play a major role in shaping the future of drug delivery domain
-
ViiV’s long-acting two-drug HIV regimen hits targets
pharmatimes
July 26, 2017
A long-acting, two-drug HIV regimen being co-developed by ViiV Healthcare and Janssen Sciences Ireland UC has shown comparable viral suppression rates to a three-drug regimen in a Phase II trial
-
China’s distribution changes force major US company out
pharmafile
July 26, 2017
Cardinal Health, one of the largest drug distributors in the US, is looking to sell on its network in China, before the ‘two-invoice’ system is implemented next year,
-
US ophthalmic drugs market set to pass $34bn by 2025
europeanpharmaceuticalreview
July 26, 2017
Major market players across the US are upping investments in research to innovate on treatment methods and improve ophthalmic drugs action…
-
Monthly injectable HIV treatment proves as effective as traditional daily pill regimen
pharmafile
July 25, 2017
New early trial data suggests that current daily HIV pill regimens could be replaced with injections which slowly release medication for the virus over time.
-
Biomedic Consulting inks strategic deal with Taiwan, China Biomed
biospectrumasia
July 25, 2017
Both the companies, together aim to focus on providing Taiwan, Chinaese medical devices companies in-depth market intelligence and new market entry strategies in Europe and USA
-
Korean Pharma Association mulls on use of AI to speed drug discovery
translate
July 25, 2017
The Korea Pharmaceutical and Bio-pharma Manufacturers Association (KPBMA) recently announced plans to create an AI-backed drug development support center this year to expedite ongoing efforts by local drugmakers to develop new blockbuster therapies for di
-
ISPE updates guidance on risk-based manufacturing
europeanpharmaceuticalreview
July 24, 2017
New ISPE guidance provides a scientific, risk-based approach for managing cross-contamination risk within shared facilities …
-
27 Phase III and 8 Phase II Alzheimer's drugs on track to launch in next 5 years
worldpharmanews
July 21, 2017
according to a revised Alzheimer's pipeline analysis presented at the Alzheimer's Association International Conference (AAIC) by ResearchersAgainstAlzheimer's (RA2)
-
Drug and alcohol testing: An expanding market
europeanpharmaceuticalreview
July 11, 2017
The demand for drug and alcohol testing in the UK is at an all-time high and the market is growing rapidly, says Livingstone’s Barry Sheehan…
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
